RecruitingNot ApplicableNCT06853886

Gene Discovery in CHB Patients to Identify Unknown Pathways That Lead to B and NK Cell Deregulation


Sponsor

University Hospital, Limoges

Enrollment

140 participants

Start Date

Aug 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Natural Killer (NK) and B cell immune responses occur during the early stages of infection and are essential to eradicate it. Yet, chronic hepatitis B (CHB) infection occurs because the antiviral immune response is insufficient. In both NK and B cell studies we will explore the genetic alterations that occur during the varied chronic stages of the disease. We believe that our findings will allow us to understand the molecular signature of NK and B cells in the context of HBV infection.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This research study looks at the genes of people with chronic hepatitis B (a long-term liver infection caused by the hepatitis B virus) to understand why the immune system's B and NK cells don't work properly in fighting the virus. Healthy volunteers are also included for comparison. **You may be eligible if:** - You are 18 years or older - You have chronic hepatitis B infection (treated or untreated) - You are willing to give written consent and are enrolled in the French social security system - Healthy volunteers aged 18–80 who do not have hepatitis B are also eligible **You may NOT be eligible if:** - You have another liver infection (hepatitis C, HIV, or hepatitis D) - You had a serious liver flare-up in the past year - You have other liver conditions (alcoholism, severe obesity, diabetes, or metabolic syndrome) - You have an immune disease or cancer - You are pregnant or breastfeeding - You have a significant disability or are under legal guardianship Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERblood sample HBV patient

During a boold sample at only one follow up visit: * 3 tubes EDTA 10 ml per patient * 1 tube "Paxgene" 1ml * 2 dry tube per patient

OTHERblood sample healthy volunteers

* 3 tubes EDTA ideally age and sex matched to CHB patient. * 1 tube "Paxgene" 1ml * 2 dry tube


Locations(3)

Centre d'Investigation Clinique

Limoges, France

Limoges University Hospital

Limoges, France

Hospice civils de Lyon

Lyon, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06853886